Completed Infection & Immunity
RECOVERY/Phase 2 Therapeutic Trials Reconfiguration
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by MRC.
View the original record at the funder ↗
Researchers
Martin Landray (Principal Investigator)Peter Horby (Co-Investigator)
Related Research
Grants with similar aims, by meaning.
RECOVERY (Randomised Evaluation of COVID-19 Therapy) International
RECOVERY - Randomised Evaluation of COVID-19 Therapy
Experimental Medicine INitiative to Explore New Therapies - Phase 2
A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma
Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to Tumor Necrosis Factor Receptor 2 (TNFR2), as a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Malignancies
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know